321 related articles for article (PubMed ID: 8117665)
1. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
Nguyen Q; Willenbrock F; Cockett MI; O'Shea M; Docherty AJ; Murphy G
Biochemistry; 1994 Mar; 33(8):2089-95. PubMed ID: 8117665
[TBL] [Abstract][Full Text] [Related]
2. Structure-function relationships in the tissue inhibitors of metalloproteinases.
Willenbrock F; Murphy G
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S165-70. PubMed ID: 7952654
[TBL] [Abstract][Full Text] [Related]
3. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.
Willenbrock F; Crabbe T; Slocombe PM; Sutton CW; Docherty AJ; Cockett MI; O'Shea M; Brocklehurst K; Phillips IR; Murphy G
Biochemistry; 1993 Apr; 32(16):4330-7. PubMed ID: 8476862
[TBL] [Abstract][Full Text] [Related]
4. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
5. Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions.
Butler GS; Apte SS; Willenbrock F; Murphy G
J Biol Chem; 1999 Apr; 274(16):10846-51. PubMed ID: 10196161
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
7. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).
Shapiro SD; Fliszar CJ; Broekelmann TJ; Mecham RP; Senior RM; Welgus HG
J Biol Chem; 1995 Mar; 270(11):6351-6. PubMed ID: 7890773
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin.
Baragi VM; Fliszar CJ; Conroy MC; Ye QZ; Shipley JM; Welgus HG
J Biol Chem; 1994 Apr; 269(17):12692-7. PubMed ID: 8175679
[TBL] [Abstract][Full Text] [Related]
9. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.
Crabbe T; Zucker S; Cockett MI; Willenbrock F; Tickle S; O'Connell JP; Scothern JM; Murphy G; Docherty AJ
Biochemistry; 1994 May; 33(21):6684-90. PubMed ID: 7911325
[TBL] [Abstract][Full Text] [Related]
11. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant.
Murphy G; Nguyen Q; Cockett MI; Atkinson SJ; Allan JA; Knight CG; Willenbrock F; Docherty AJ
J Biol Chem; 1994 Mar; 269(9):6632-6. PubMed ID: 8120015
[TBL] [Abstract][Full Text] [Related]
13. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.
Gallegos NC; Smales C; Savage FJ; Hembry RM; Boulos PB
Surg Oncol; 1995; 4(2):111-9. PubMed ID: 7551259
[TBL] [Abstract][Full Text] [Related]
14. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2.
Bigg HF; Shi YE; Liu YE; Steffensen B; Overall CM
J Biol Chem; 1997 Jun; 272(24):15496-500. PubMed ID: 9182583
[TBL] [Abstract][Full Text] [Related]
15. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis.
Rifas L; Fausto A; Scott MJ; Avioli LV; Welgus HG
Endocrinology; 1994 Jan; 134(1):213-21. PubMed ID: 8275936
[TBL] [Abstract][Full Text] [Related]
16. Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV.
Overall CM; King AE; Sam DK; Ong AD; Lau TT; Wallon UM; DeClerck YA; Atherstone J
J Biol Chem; 1999 Feb; 274(7):4421-9. PubMed ID: 9933646
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B.
O'Connell JP; Willenbrock F; Docherty AJ; Eaton D; Murphy G
J Biol Chem; 1994 May; 269(21):14967-73. PubMed ID: 8195131
[TBL] [Abstract][Full Text] [Related]
18. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
Itoh Y; Ito A; Iwata K; Tanzawa K; Mori Y; Nagase H
J Biol Chem; 1998 Sep; 273(38):24360-7. PubMed ID: 9733724
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis.
Hembry RM; Bagga MR; Reynolds JJ; Hamblen DL
Ann Rheum Dis; 1995 Jan; 54(1):25-32. PubMed ID: 7880117
[TBL] [Abstract][Full Text] [Related]
20. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma.
Moutsiakis D; Mancuso P; Krutzsch H; Stetler-Stevenson W; Zucker S
Connect Tissue Res; 1992; 28(3):213-30. PubMed ID: 1468208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
